Results: 9
Levothyroxine Treatment Among Pregnant Women and Risk of Seizure in Children: A Population-Based Cohort Study.
- Published in:
- Drug Safety, 2023, v. 46, n. 11, p. 1149, doi. 10.1007/s40264-023-01352-x
- By:
- Publication type:
- Article
Adverse Drug Reactions to Opioids: A Study in a National Pharmacovigilance Database.
- Published in:
- Drug Safety, 2023, v. 46, n. 11, p. 1133, doi. 10.1007/s40264-023-01351-y
- By:
- Publication type:
- Article
22nd ISoP Annual Meeting "Putting Patients First in Pharmacovigilance: International Perspectives from Global South" 6–9 November 2023 Bali, Indonesia.
- Published in:
- 2023
- Publication type:
- Calendar
Development and Application of a Data-Driven Signal Detection Method for Surveillance of Adverse Event Variability Across Manufacturing Lots of Biologics.
- Published in:
- Drug Safety, 2023, v. 46, n. 11, p. 1117, doi. 10.1007/s40264-023-01349-6
- By:
- Publication type:
- Article
Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes.
- Published in:
- Drug Safety, 2023, v. 46, n. 11, p. 1161, doi. 10.1007/s40264-023-01348-7
- By:
- Publication type:
- Article
Association of Strict Versus Lenient Cholesterol Lowering with Cardiac Outcomes, Diabetes Progression and Complications, and Mortality in Patients with Diabetes Treated with Statins: Is Less More?
- Published in:
- Drug Safety, 2023, v. 46, n. 11, p. 1105, doi. 10.1007/s40264-023-01347-8
- By:
- Publication type:
- Article
An Exploratory Study of the Impact of COVID-19 Vaccine Spontaneous Reporting on Masking Signal Detection in EudraVigilance.
- Published in:
- Drug Safety, 2023, v. 46, n. 11, p. 1089, doi. 10.1007/s40264-023-01346-9
- By:
- Publication type:
- Article
Evolution of Cross-Sectional Survey Protocol Quality Over Time: A Case Series of Index U.S. REMS Knowledge Survey Protocols (2007–2020).
- Published in:
- Drug Safety, 2023, v. 46, n. 11, p. 1073, doi. 10.1007/s40264-023-01344-x
- By:
- Publication type:
- Article
Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors.
- Published in:
- Drug Safety, 2023, v. 46, n. 11, p. 1049, doi. 10.1007/s40264-023-01333-0
- By:
- Publication type:
- Article